Your session is about to expire
← Back to Search
Continuous Infusion of Bupivacaine for Pain Management
Phase 3
Waitlist Available
Led By Tarik Wasfie, MD
Research Sponsored by Ascension Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 days
Awards & highlights
Summary
This trial looked at whether using a continuous infusion of local anesthetic for postoperative pain control following laparotomy is more effective than using a local anesthetic infiltration technique.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 days
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Self Reported Pain
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: Infused analgesicActive Control1 Intervention
Patients will be assigned to receive local anesthetic through continuous infusion by pump.
Group II: Infused salinePlacebo Group1 Intervention
Patients will be assigned to receive saline through continuous infusion by pump.
Find a Location
Who is running the clinical trial?
Ascension HealthLead Sponsor
26 Previous Clinical Trials
2,762 Total Patients Enrolled
Ascension Genesys HospitalLead Sponsor
18 Previous Clinical Trials
1,943 Total Patients Enrolled
Tarik Wasfie, MDPrincipal InvestigatorAscension Health
2 Previous Clinical Trials
261 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are taking medication for long-term pain relief.You recently had an emergency surgery on your abdomen.You are pregnant.
Research Study Groups:
This trial has the following groups:- Group 1: Infused saline
- Group 2: Infused analgesic
Awards:
This trial has 1 awards, including:- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger